Physician
Total Family Care of 5 Towns & Rockaway
Total Family Care of 5 Towns & Rockaway was paid $5.14M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoTOTAL FAMILY CARE OF 5 TOWNS & ROCKAWAY
FAR ROCKAWAY, NY 11691
FAR ROCKAWAY, NY 11691
33aNPI1073656930assigned 02/14/2007
33bProvider typeAllergy & Immunology Physician
28Total paid$5.14M
24GClaims157,132
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in New York
Rank by total paid#2 of 135
Median peer was paid$34K
This provider vs. median153×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,909 | $224K | |
| 2019 | 14,964 | $377K | |
| 2020 | 28,015 | $739K | |
| 2021 | 28,303 | $994K | |
| 2022 | 29,216 | $1.03M | |
| 2023 | 27,419 | $988K | |
| 2024incomplete | 21,306 | $784K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 29,056 | 23,459 | $2.27M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 5,010 | 4,542 | $595K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.2% | 3,845 | 3,839 | $372K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.4% | 3,360 | 3,359 | $327K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.1% | 2,897 | 2,832 | $262K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 2,384 | 2,384 | $254K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.5% | 4,536 | 4,328 | $230K |
| 92587 | 4.2% | 6,348 | 6,342 | $213K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.0% | 12,677 | 12,292 | $204K |
| 99051 | <1% | 8,093 | 7,585 | $49K | |
| 99188 | <1% | 4,110 | 4,105 | $46K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 393 | 392 | $45K |
53 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,836 | $41K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,830 | $39K |
| 92551 | <1% | 5,153 | $36K | |
| 96127 | <1% | 3,472 | $18K | |
| 87070 | <1% | 2,671 | $17K | |
| 81003 | <1% | 7,040 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 278 | $12K |
| 92552 | <1% | 728 | $11K | |
| 90677 | <1% | 260 | $10K | |
| 97802 | <1% | 4,404 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 48 | $9K |
| 90651 | <1% | 622 | $9K | |
| 90461 | <1% | 2,736 | $7K | |
| 83655 | <1% | 646 | $7K | |
| 90620 | <1% | 97 | $6K | |
| 90686 | <1% | 4,505 | $5K | |
| 99401 | <1% | 5,083 | $4K | |
| 69210 | <1% | 86 | $4K | |
| 96161 | <1% | 2,226 | $4K | |
| 99381 | <1% | 13 | $2K | |
| 17110 | <1% | 17 | $1K | |
| 99177 | <1% | 3,442 | $1K | |
| 90671 | <1% | 112 | $992.16 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 843 | $940.52 |
| 90710 | <1% | 615 | $866.20 | |
| 81002 | <1% | 448 | $784.60 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 112 | $738.12 |
| 90715 | <1% | 148 | $609.29 | |
| 99173 | <1% | 5,833 | $520.36 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 46 | $458.85 |
| 96160 | <1% | 365 | $406.21 | |
| 90656 | <1% | 283 | $230.58 | |
| 90734 | <1% | 475 | $169.13 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 847 | $157.60 |
| 90723 | <1% | 1,303 | $101.94 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 46 | $94.69 |
| 94664 | <1% | 13 | $65.97 | |
| 90672 | <1% | 567 | $55.58 | |
| 90633 | <1% | 830 | $41.37 | |
| 90647 | <1% | 1,320 | $33.73 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 37 | $33.67 |
| 90660 | <1% | 43 | $28.88 | |
| 92283 | <1% | 159 | $25.00 | |
| 99000 | <1% | 2,296 | $3.35 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 42 | $1.73 |
| 90696 | 0% | 104 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 92 | $0.00 |
| 90681 | 0% | 698 | $0.00 | |
| 90670 | 0% | 1,338 | $0.00 | |
| 90700 | 0% | 134 | $0.00 | |
| 90648 | 0% | 31 | $0.00 | |
| 90685 | 0% | 20 | $0.00 | |
| 99354 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIGHTMAN, HYLTON (OWNER)